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Catalogue of Somatic Mutations in Cancer (COSMIC) (http://www.sanger.ac.uk/cosmic) is a publicly available resource
providing information on somatic mutations implicated in human cancer. Release v51 (January 2011) includes data from
just over 19000 genes, 161787 coding mutations and 5573 gene fusions, described in more than 577000 tumour samples.
COSMICMart (COSMIC BioMart) provides a flexible way to mine these data and combine somatic mutations with other
biological relevant data sets. This article describes the data available in COSMIC along with examples of how to successfully
mine and integrate data sets using COSMICMart.
Database URL: http://www.sanger.ac.uk/genetics/CGP/cosmic/biomart/martview/
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Project description
COSMIC is a repository for somatic mutations and associ-
ated phenotype/clinical information, combining data from a
number of sources. Primarily, data are manually curated from
the scientific literature for genes selected from the Cancer
Gene Census (http://www.sanger.ac.uk/genetics/CGP/
Census/), a listing of genes that are known to be mutated
in human cancer. The manual curation initially focused on
known cancer genes that had a high proportion of coding
point mutations. In recent years, this has been extended to
include cancer genes that are also mutated by gene fusion
events. With the advent of next-generation sequencing,
COSMIC has been adapted to hold complete catalogues
of somatic mutations for individual tumour samples.
The COSMIC website has been developed to overview the
underlying database in a user-friendly manner. The website
can be navigated by gene, cancer sample or tissue/histology
type and has a series of graphical and tabular displays to
summarize the content of the database.
However, the integration of biological data sets is still a
major IT challenge. Although, the data in COSMIC can be
viewed and downloaded in a number of useful ways, it is
still challenging for users to generate their own custom
queries and also to link to related resources. In order to
facilitate the integration of the COSMIC data set, we have
used the BioMart data mining software. BioMart uses a
federated data model to allow integration of biological
data from diverse databases (1). There is now a significant
number of data resources that have set up their own
BioMarts including Ensembl, UniProt and HGNC. The
BioMart software also has interfaces that allow users to
easily generate custom queries to obtain subsets of data
from one or more BioMart data resources. We have success-
fully set up an instance of a BioMart, COSMICMart, which
holds a summary of the somatic mutations and associated
phenotype data from the COSMIC database.
Data content
COSMIC version 51 (January 2011) contains a full curation
of the scientific literature for 91 cancer genes, mostly
point-mutated, as well as 53 curated fusion gene pairs,
with over 11000 papers having been assessed. Weekly
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and each abstract/article is manually evaluated. Checks
are made to ensure a paper has not been curated already,
whether the paper is a review or is reporting original data,
if there are any inconsistencies in the data, and whether all
the required information for full curation is present, e.g.
information on the numbers of samples screened and suf-
ficient mutation detail. Papers which pass the initial scan
are submitted for detailed manual curation, while the
remaining papers are ‘listed’ on the COSMIC website.
Information is manually recorded on the actual mutation
change, the detailed phenotype of the cancer samples and
the original publication/study.
Mutation changes are checked for accuracy and recorded
at the genome, transcript (to one reference transcript) and
protein level using the mutation syntax standards de-
veloped by the Human Genome Variation Society (2).
Negative results (sample screened does not have a muta-
tion for a particular gene for a particular publication) are
also recorded so prevalence statistics can be estimated for
each gene. As part of the curation process, cancer sample
tissue/histology descriptions from the original publication
are recorded and then re-classified to a COSMIC standard
tissue/histology ontology (See classification section of the
COSMIC additional information page, http://www.sanger
.ac.uk/genetics/CGP/cosmic/add_info/). The standardization
of the main data types in COSMIC means the utility of the
data is significantly enhanced and the data are easier to
browse and incorporate into external data sets. When avail-
able, clinical and exposure data and therapeutic responses
are also recorded. The full functionality of COSMIC has
previously been described (3, 4).
The database coverage has recently been enhanced by
the integration of somatic mutations from external data
resources. A collaboration with the database curators at
International Agency for Research on Cancer (IARC) has
allowed the majority of mutations from IARC TP53 data-
base R14 to be integrated into COSMIC (5). Somatic muta-
tions from large-scale systematic cancer screens are curated
in COSMIC to include studies on glioblastoma multiforme,
breast, colorectal and lung cancer (6–9). Data are also
directly curated from the data portals of large-scale pro-
jects to include the Cancer Genome Project (CGP) at the
Sanger Institute and more recently validated somatic
mutations from The Cancer Genome Atlas (TCGA) (6) and
International Cancer Genome Consortium (ICGC) (10).
COSMIC has been enhanced to accommodate somatic
mutations from whole genome and exome screens. This
includes all somatic and non-coding mutations, structural
rearrangements and gene fusions. Currently, COSMIC has
annotated 51 genomes and 332 exomes from a range of
cancers to include lung, malignant melanoma, renal, AML,
pancreatic and ovarian cancer. The current contents of the
database (v51, January 2011) are displayed in Table 1.
Query examples
COSMICMart allows data to be filtered on six different cate-
gories (Figure 1): cancer sample, gene, mutation, site of the
tumour, histology and other (e.g. Ensembl Gene ID,
Swissprot ID, Entrez Gene ID). The interface has a number
of pre-selected filters and attributes; mutated samples are
selected by default. Users can change these to suit their
requirements. Results are displayed in tabulated form and
are exportable in various formats for further analysis.
Query #1: ‘Find all missense substitution mutations for
BRAF in cell lines, and display sample, mutation, site, and
histology information’ (Figure 1, Table 2).
Missense mutations are the most common variant type
in COSMIC; over 90% of mutations in BRAF are missense
mutations at the p.V600 position. The results are returned
as a tabular summary with links back to the COSMIC web-
site. The sample name field links back to the COSMIC
sample overview web page, and mutation ID (COSM ID)
to the COSMIC mutation summary page (Figure 2). From
the COSMIC mutation summary web page, there are links
to the Ensembl contig view so the mutation can be viewed
in a genomic context. There are also links to the GMOD’s
GBrowse where COSMIC coding and non-coding mutations,
gene footprints, structural rearrangements and copy
number variants can be viewed (11).
Query #2: ‘Find all gene fusion mutations involving the
FUS gene with a primary site of bone, and display mutation
and sample information’ (Table 3).
Gene fusions have been associated with a number of
specific tumour types including prostate and blood tu-
mours. These biomarkers can be useful in diagnosis and
as targets for drug therapies. COSMIC has annotations,
for an increasing number of gene fusion mutations, which
are viewable using COSMICMart. The COSMIC fusion muta-
tion ID links to the gene fusion summary pages, which give
a graphical view of different fusion structures observed.
Many of the papers describing gene fusions have identified
Table 1. Total contents in v51 of the COSMIC database,
January 2011 release
Curated data type Curated data count
Experiments 2946792
Tumours 577304
Mutations 167193
References 11062
Genes 19000
Fusions 5573
Structural variants 2729
Whole-cancer genomes 51
Whole-cancer exomes 332
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single sample. Observed mRNAs are the actual expressed
products reported in the results. However, to aid display
and website navigation, we have inferred the genomic
breakpoint from the experimental data.
Query #3: ‘Find variation information in Ensembl for all
genes from mutated samples with a primary site of breast,
and display COSMIC gene, mutation and sample informa-
tion along with Ensembl variation information’ (Table 4).
Figure 1. Example of how COSMICMart can be queried. This query searches for all cell lines with missense substitution mutations
in the BRAF gene (A). Attributes can be selected (B) to display in the results table (C).
Table 2. Data sets, filters and attributes selected for query #1
Data sets Filters Attributes
COSMIC51 Mutated sample: yes Sample name
Sample source: cell-line Sample source
Gene name: BRAF Gene name
AA mutation type:
substitution—missense
Cosmic mutation ID
(COSM ID)
CDS mutation syntax
AA mutation syntax
Primary site
Primary histology
Tumour source
Pubmed ID
Table 3. Data sets, filters and attributes selected for query #2
Data sets Filters Attributes
COSMIC51 Mutated sample: yes Cosmic sample ID
Gene name: FUS Sample name
CDS mutation type:
inferred breakpoint,
observed mRNA
Sample source
Primary site: bone Cosmic fusion mutation ID
CDS mutation syntax
Pubmed ID
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allows Biomart queries to return and integrate data from
both resources. For instance, the linking of the two re-
sources can allow the retrieval of variation data from
both resources (somatic mutations from COSMIC and germ-
line polymorphisms from Ensembl) for a particular gene or
set of genes or cancer type. There is an increasing aware-
ness of how genomic variation can affect a tumour’s sensi-
tivity or resistance to anti-cancer agents. While this genetic
variation can be familial or somatic, an understanding of
common genetic variation around known cancer genes can
be of much value to investigations searching for loci mod-
ifying a tumour’s response to drug therapy (13–15). This
query is achieved by first selecting the filters/attributes in
the COSMIC BioMart and then clicking the ‘Dataset’ link at
the bottom of the left hand margin of the BioMart inter-
face. An additional data set can then be selected from the
drop down list, in this instance Ensembl, which allows a
federated query between COSMIC and Ensembl. The fil-
ters/attributes are then set in the usual way using the
Ensembl BioMart to produce an integrated query.
Future directions
COSMIC will continue to curate newly discovered cancer
genes and is committed to update existing cancer genes
with a data release every 2 months. This will ensure that
the scientific community has an up-to-date catalogue
of somatic mutations implicated in human cancer.
COSMICMart is also automatically updated with each new
COSMIC release, which allows the data set to be easily
mined and integrated with other resources. COSMIC has
been successfully adapted to hold complete catalogues of
somatic mutations for individual cancer samples. Currently
COSMIC holds genome-wide data on 383 tumour samples
and we expect this to increase in the near future.
It is intended to federate COSMICMart with further
BioMart-driven data resources in addition to the current
link with Ensembl. Linking our data to PRIDE (16), UniProt
(17) and InterPro (18) will allow COSMIC somatic mutation
data to be linked to protein and peptide annotation, while
the addition of the Reactome (19) database will allow the
incorporation of pathway data. We also intend to create
direct links between COSMIC and the ICGC Data Portal
(http://dcc.icgc.org/) so somatic mutation data can be inte-
grated between the two data resources.
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